|
|
Merck buying Schering-Plough in a $41.1B deal
TRENTON, N.J. - Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in a deal that gives Merck key new businesses, access to a promising pipeline of new products and the chance to further cut costs, including eliminating about 16,000 jobs.
2009-03-09
FDA backs Vytorin after finishing study review
TRENTON, N.J. - The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales.
Source:(AP)
2009-01-09
Pfizer, Schering-Plough beat modest expectations
TRENTON, N.J. - Pfizer Inc. and Schering-Plough Corp. both managed to beat analysts' minimal expectations Tuesday, largely because of revenue buoyed by favorable currency exchange rates and growing sales overseas making up for slumping sales at home.
Nations:U.S. Switzerland Source:(AP)
2008-10-21
Schering-Plough, Merck's Vytorin misses study goal
TRENTON, N.J. - In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery, sending its makers' stock plunging.
2008-07-21
Lawmakers call on drug companies to curb ads
Two top Democratic lawmakers called on several drug companies on Tuesday to voluntarily curb advertisements targeting consumers, including withholding any ads for new products for two years.
People:John Dingell
2008-05-21
|